Sequential Valproic Acid/All-trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Sequential Valproic Acid/All-trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia

Published:2006-09-01 Issue:17 Volume:66 Page:8903-8911
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Cimino Giuseppe,Lo-Coco Francesco,Fenu Susanna,Travaglini Lorena,Finolezzi Erica,Mancini Marco,Nanni Mauro,Careddu Angela,Fazi Francesco,Padula Fabrizio,Fiorini Roberto,Aloe Spiriti Maria Antonietta,Petti Maria Concetta,Venditti Adriano,Amadori Sergio,Mandelli Franco,Pelicci Pier Giuseppe,Nervi Clara

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. All-trans retinoic acid induces durable tumor immunity in IDH-mutant gliomas by rescuing transcriptional repression of the CRBP1-retinoic acid axis;2024-04-13

2. All-trans-retinoic acid and valproic acid: A combinatorial approach for the treatment of nephrotic syndrome;Current Research in Biotechnology;2024

3. Efficacy and Safety of Valproic Acid in Myelodysplastic Syndrome and Acute Myeloid Leukemia; a Narrative Review;Drug Research;2023-05-23

4. The epigenetic regulation of cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence;Advances in Cancer Research;2023

5. Epigenetic compounds targeting pharmacological target lysine specific demethylase 1 and its impact on immunotherapy, chemotherapy and radiotherapy for treatment of tumor recurrence and resistance;Biomedicine & Pharmacotherapy;2023-01